RFA-GH-20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
RFA-GH-20-005,在秘鲁进行综合传染病和公共卫生研究
基本信息
- 批准号:10842492
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY:
The proposed application aims to overcome diagnostic barriers in the etiologic diagnosis of endemic and
epidemic causes of acute febrile illness (AFI) by moving efficient state of the art diagnostics to an area of high
endemicity. The long-term goal of this research is to understand the etiology of AFI across diverse contexts in
South America and contribute to global strategies that improve etiology-specific disease estimates to inform
public health practice and policy. The central hypothesis is that the technology transfer and implementation of
improved diagnostics will enhance regional diagnostic capacity, epidemic responsiveness, and translation of
research findings to practice maximizing the public health impact of research findings. The rationale for the
research is that the documented feasibility of this approach will enable a full and appropriate evaluation for
uptake by regional and national stakeholders. The goals of the research will be achieved through the execution
of three specific aims: 1) Establish stable year round acute febrile illness surveillance using the TaqMan array
card, which simultaneously detects over 30 pathogens of AFI across three epidemiologic contexts in Loreto,
Peru; urban, riverine with extensive sylvatic exposure, and agricultural riverine context along the three country
border (Peru, Brazil, and Colombia) in order to capture the diversity of pathogens causing AFI in Peru over a
four year period; 2) Integrate this diagnostic platform into the regional outbreak response to determine the
etiology of epidemics of acute febrile illness and validating improved storage and transport procedures; and 3)
Develop and evaluate novel serodiagnostic chip to enable single platform serologic assessment and downstream
point of care tests and focused diagnostics for pathogens of high prevalence and importance. The global control
of emerging infectious diseases will be improved only as the areas that are not reached and included effectively
in surveillance shrink and the proposed project attempts to implement a strategy to make all populations
reachable to the improved diagnostics. The complexity of current diagnostic strategies is a critical barrier to the
timely regional ascertainment of the etiology of most cases of acute febrile illnesses and this has important
regional and global public health implications as undiagnosed AFI allows for the widespread dissemination of
emerging diseases as effective disease control measures are based on accurate etiologic assessment. The plan
is innovative because of the meaningful integration of highly select local researchers, educators, trainees, and
policymakers. The implementation of the research strategy will be significant because it is expected to contribute
to the accuracy of etiologic assessment of endemic and epidemic etiologies of AFI in an area of documented
diversity of vector-borne and zoonotic agents and serve as a model for enabling local diagnostic and reporting
capacity in South America.
项目摘要:
拟议的应用旨在克服特有和
通过将有效的最先进诊断状态移动到一个高度的领域,导致急性发热疾病(AFI)的流行病原因
流行性。这项研究的长期目标是了解跨不同背景的AFI的病因
南美并促进了改善病因特异性疾病估计以告知的全球策略
公共卫生实践和政策。中心假设是技术转移和实施
改进的诊断将提高区域诊断能力,流行性反应能力以及翻译
研究结果是为了实践最大化研究结果的公共卫生影响。理由
研究是,这种方法的可行性将使能够进行完整而适当的评估
地区和国家利益相关者的吸收。研究的目标将通过执行实现
在三个具体目标中:1)使用塔克曼阵列建立全年稳定的急性高热疾病监视
卡,在洛雷托的三个流行病学环境中同时检测到30多个病原体AFI,
秘鲁;城市,河流,具有广泛的Sylvatic暴露以及三个国家的农业河流环境
边境(秘鲁,巴西和哥伦比亚),以捕获秘鲁在秘鲁的病原体多样性
四年期; 2)将此诊断平台集成到区域爆发响应中,以确定
急性发热疾病流行病的病因,并验证了改进的存储和运输程序; 3)
开发和评估新型的血清诊断芯片,以实现单个平台的血清学评估和下游
护理点测试和重点诊断,以示较高的患病率和重要性。全球控制
新兴的传染病仅在未达到并有效包括的区域时得到改善
在监视缩水和拟议的项目中,试图实施一项策略以使所有人口
可及改进的诊断。当前诊断策略的复杂性是对
及时确定大多数急性发热疾病病例的病因,这很重要
未经诊断的AFI的区域和全球公共卫生影响允许广泛传播
作为有效疾病控制措施的新兴疾病基于准确的病因学评估。计划
由于高度精选的本地研究人员,教育者,学员和
决策者。研究策略的实施将是重要的,因为它有望做出贡献
为了对AFI的流行病和流行病学的病因学评估的准确性
向量传播和人畜共患剂的多样性,并作为实现本地诊断和报告的模型
南美的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret N Kosek其他文献
Margaret N Kosek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret N Kosek', 18)}}的其他基金
Capacity building in climate and health in the Peruvian Amazon
秘鲁亚马逊地区气候和健康方面的能力建设
- 批准号:
10838170 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Genomic features of host adaptation of Campylobacter in low-income settings
低收入环境中弯曲杆菌宿主适应的基因组特征
- 批准号:
10615827 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Genomic features of host adaptation of Campylobacter in low-income settings
低收入环境中弯曲杆菌宿主适应的基因组特征
- 批准号:
10452900 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
- 批准号:
10371146 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
- 批准号:
10600981 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
- 批准号:
10184256 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10259643 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10425210 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10462449 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Enabling Infectious Disease Research Capacity in the Peruvian Amazon
增强秘鲁亚马逊地区的传染病研究能力
- 批准号:
10361568 - 财政年份:2018
- 资助金额:
$ 10万 - 项目类别:
相似国自然基金
基于变形损伤控制机制的GH4169及焊接接头的蠕变-疲劳-临氢环境下寿命预测研究
- 批准号:52375371
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
马铃薯块茎蛾肠道共生Glutamicibacter halophytocola GH202103 降解马铃薯糖苷生物碱的机制研究
- 批准号:32360711
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
海洋细菌来源GH18家族关键酶高效水解结晶几丁质的机制与定向改造
- 批准号:42306118
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
航空发动机GH4169合金拘束相关的疲劳寿命预测研究
- 批准号:
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:
GH/GHR信号转导在肝脏胆汁酸代谢调控中的作用及机制研究
- 批准号:32300991
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
RFA-GH-20-005, Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)
RFA-GH-20-005,安第斯和亚马逊国家发热性疾病监测项目 (PISAAC)
- 批准号:
10669093 - 财政年份:2021
- 资助金额:
$ 10万 - 项目类别:
a novel therapy of functioning pituitary adenomas using attenuated secretory machinery focusing porosome
使用聚焦多孔体的减弱分泌机制治疗功能性垂体腺瘤的新疗法
- 批准号:
20591723 - 财政年份:2008
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY
生长激素缺乏症青春期儿童 Nutropin 治疗的 III 期研究
- 批准号:
6578990 - 财政年份:2002
- 资助金额:
$ 10万 - 项目类别:
LRF ANALOG TO DELAY PUBERTY IN PRECOCIOUS PUBERTY, GH DEFICIENCY, SHORT STATURE
LRF 类似物可延迟性早熟、生长激素缺乏、身材矮小患者的青春期
- 批准号:
6586448 - 财政年份:2002
- 资助金额:
$ 10万 - 项目类别:
PHASE III STUDY OF NUTROPIN THERAPY IN PUBERTAL CHILDREN WITH GH DEFICIENCY
生长激素缺乏症青春期儿童 Nutropin 治疗的 III 期研究
- 批准号:
6477517 - 财政年份:2001
- 资助金额:
$ 10万 - 项目类别: